Luigi Tornillo
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Gastrointestinal Tumor Research and Treatment, Genetic factors in colorectal cancer, Immune Cell Function and Interaction
Most-Cited Works
- → PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients(2014)603 cited
- → Clinical impact of programmed cell death ligand 1 expression in colorectal cancer(2013)446 cited
- → Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients(2013)441 cited
- → Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis(2007)417 cited
- → Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers(2006)382 cited
- → High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patients(2009)328 cited
- → Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer(2010)309 cited
- → Glypican 3 Expression in Human Nonneoplastic, Preneoplastic, and Neoplastic Tissues(2008)262 cited
- → YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors(2015)245 cited
- → The Interplay Between Neutrophils and CD8+ T Cells Improves Survival in Human Colorectal Cancer(2017)241 cited